Given that deregulated neddylation has been established as a feature of AD pathogenesis [222], it has been demonstrated that melatonin pre-treatment prevents the Aβ42-induced enhancement of APP-BP1 protein expression and the alteration of NEDD8 cellular localization [223]. Here, APP is linked to Alzheimer disease.